140 related articles for article (PubMed ID: 31627705)
1. Glycoproteins in the Sera of Oncological Patients.
Hernychová L; Uhrík L; Nenutil R; Novotný MV
Klin Onkol; 2019; 32(Supplementum 3):39-45. PubMed ID: 31627705
[TBL] [Abstract][Full Text] [Related]
2. Glycans as cancer biomarkers.
Adamczyk B; Tharmalingam T; Rudd PM
Biochim Biophys Acta; 2012 Sep; 1820(9):1347-53. PubMed ID: 22178561
[TBL] [Abstract][Full Text] [Related]
3. Breast cancer diagnosis and prognosis through quantitative measurements of serum glycan profiles.
Kyselova Z; Mechref Y; Kang P; Goetz JA; Dobrolecki LE; Sledge GW; Schnaper L; Hickey RJ; Malkas LH; Novotny MV
Clin Chem; 2008 Jul; 54(7):1166-75. PubMed ID: 18487288
[TBL] [Abstract][Full Text] [Related]
4. Glycan-based biomarkers for diagnosis of cancers and other diseases: Past, present, and future.
Hu M; Lan Y; Lu A; Ma X; Zhang L
Prog Mol Biol Transl Sci; 2019; 162():1-24. PubMed ID: 30905444
[TBL] [Abstract][Full Text] [Related]
5. Glycosylation markers in cancer.
Silsirivanit A
Adv Clin Chem; 2019; 89():189-213. PubMed ID: 30797469
[TBL] [Abstract][Full Text] [Related]
6. Cancer serum biomarkers based on aberrant post-translational modifications of glycoproteins: Clinical value and discovery strategies.
Silva ML
Biochim Biophys Acta; 2015 Dec; 1856(2):165-77. PubMed ID: 26232626
[TBL] [Abstract][Full Text] [Related]
7. The sensitivity and specificity of serum glycan-based biomarkers for cancer detection.
Tang Y; Cui Y; Zhang S; Zhang L
Prog Mol Biol Transl Sci; 2019; 162():121-140. PubMed ID: 30905445
[TBL] [Abstract][Full Text] [Related]
8. Aberrant glycosylation as biomarker for cancer: focus on CD43.
Tuccillo FM; de Laurentiis A; Palmieri C; Fiume G; Bonelli P; Borrelli A; Tassone P; Scala I; Buonaguro FM; Quinto I; Scala G
Biomed Res Int; 2014; 2014():742831. PubMed ID: 24689054
[TBL] [Abstract][Full Text] [Related]
9. Glycoprotein biomarkers for the detection of pancreatic ductal adenocarcinoma.
Llop E; E Guerrero P; Duran A; Barrabés S; Massaguer A; José Ferri M; Albiol-Quer M; de Llorens R; Peracaula R
World J Gastroenterol; 2018 Jun; 24(24):2537-2554. PubMed ID: 29962812
[TBL] [Abstract][Full Text] [Related]
10. Exploring serum and immunoglobulin G N-glycome as diagnostic biomarkers for early detection of breast cancer in Ethiopian women.
Gebrehiwot AG; Melka DS; Kassaye YM; Gemechu T; Lako W; Hinou H; Nishimura SI
BMC Cancer; 2019 Jun; 19(1):588. PubMed ID: 31208374
[TBL] [Abstract][Full Text] [Related]
11. Glycosylation-Based Serum Biomarkers for Cancer Diagnostics and Prognostics.
Kirwan A; Utratna M; O'Dwyer ME; Joshi L; Kilcoyne M
Biomed Res Int; 2015; 2015():490531. PubMed ID: 26509158
[TBL] [Abstract][Full Text] [Related]
12. Healthy human serum N-glycan profiling reveals the influence of ethnic variation on the identified cancer-relevant glycan biomarkers.
Gebrehiwot AG; Melka DS; Kassaye YM; Rehan IF; Rangappa S; Hinou H; Kamiyama T; Nishimura SI
PLoS One; 2018; 13(12):e0209515. PubMed ID: 30592755
[TBL] [Abstract][Full Text] [Related]
13. Serum N-glycan analysis in breast cancer patients--Relation to tumour biology and clinical outcome.
Haakensen VD; Steinfeld I; Saldova R; Shehni AA; Kifer I; Naume B; Rudd PM; Børresen-Dale AL; Yakhini Z
Mol Oncol; 2016 Jan; 10(1):59-72. PubMed ID: 26321095
[TBL] [Abstract][Full Text] [Related]
14. The sweet and sour of serological glycoprotein tumor biomarker quantification.
Kuzmanov U; Kosanam H; Diamandis EP
BMC Med; 2013 Feb; 11():31. PubMed ID: 23390961
[TBL] [Abstract][Full Text] [Related]
15. Developments in the identification of glycan biomarkers for the detection of cancer.
Ruhaak LR; Miyamoto S; Lebrilla CB
Mol Cell Proteomics; 2013 Apr; 12(4):846-55. PubMed ID: 23365456
[TBL] [Abstract][Full Text] [Related]
16. Serum glycome profiling: a biomarker for diagnosis of ovarian cancer.
Biskup K; Braicu EI; Sehouli J; Fotopoulou C; Tauber R; Berger M; Blanchard V
J Proteome Res; 2013 Sep; 12(9):4056-63. PubMed ID: 23889230
[TBL] [Abstract][Full Text] [Related]
17. Altered glycosylation in tumours focused to cancer diagnosis.
Peracaula R; Barrabés S; Sarrats A; Rudd PM; de Llorens R
Dis Markers; 2008; 25(4-5):207-18. PubMed ID: 19126965
[TBL] [Abstract][Full Text] [Related]
18. A strategy to reveal potential glycan markers from serum glycoproteins associated with breast cancer progression.
Abd Hamid UM; Royle L; Saldova R; Radcliffe CM; Harvey DJ; Storr SJ; Pardo M; Antrobus R; Chapman CJ; Zitzmann N; Robertson JF; Dwek RA; Rudd PM
Glycobiology; 2008 Dec; 18(12):1105-18. PubMed ID: 18818422
[TBL] [Abstract][Full Text] [Related]
19. Analysis of serum glycome by lectin microarrays for prostate cancer patients - a search for aberrant glycoforms.
Bertok T; Jane E; Chrenekova N; Hroncekova S; Bertokova A; Hires M; Vikartovska A; Kubanikova P; Sokol R; Fillo J; Kasak P; Borsig L; Tkac J
Glycoconj J; 2020 Dec; 37(6):703-711. PubMed ID: 33119808
[TBL] [Abstract][Full Text] [Related]
20. A rapid mass spectrometric strategy for the characterization of N- and O-glycan chains in the diagnosis of defects in glycan biosynthesis.
Faid V; Chirat F; Seta N; Foulquier F; Morelle W
Proteomics; 2007 Jun; 7(11):1800-13. PubMed ID: 17520685
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
